Your browser doesn't support javascript.
loading
Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
Karachaliou, Niki; Codony-Servat, Jordi; Teixidó, Cristina; Pilotto, Sara; Drozdowskyj, Ana; Codony-Servat, Carles; Giménez-Capitán, Ana; Molina-Vila, Miguel Angel; Bertrán-Alamillo, Jordi; Gervais, Radj; Massuti, Bartomeu; Morán, Teresa; Majem, Margarita; Felip, Enriqueta; Carcereny, Enric; García-Campelo, Rosario; Viteri, Santiago; González-Cao, María; Morales-Espinosa, Daniela; Verlicchi, Alberto; Crisetti, Elisabetta; Chaib, Imane; Santarpia, Mariacarmela; Luis Ramírez, José; Bosch-Barrera, Joaquim; Felipe Cardona, Andrés; de Marinis, Filippo; López-Vivanco, Guillermo; Miguel Sánchez, José; Vergnenegre, Alain; Sánchez Hernández, José Javier; Sperduti, Isabella; Bria, Emilio; Rosell, Rafael.
Afiliação
  • Karachaliou N; Instituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain.
  • Codony-Servat J; Pangaea Biotech, Barcelona, Spain.
  • Teixidó C; Pangaea Biotech, Barcelona, Spain.
  • Pilotto S; Department of Medical Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Drozdowskyj A; Pivotal, Madrid, Spain.
  • Codony-Servat C; Pangaea Biotech, Barcelona, Spain.
  • Giménez-Capitán A; Pangaea Biotech, Barcelona, Spain.
  • Molina-Vila MA; Pangaea Biotech, Barcelona, Spain.
  • Bertrán-Alamillo J; Pangaea Biotech, Barcelona, Spain.
  • Gervais R; Centre François Baclesse, Caen, France.
  • Massuti B; Hospital General de Alicante, Alicante, Spain.
  • Morán T; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Majem M; Hospital de Sant Pau, Barcelona, Spain.
  • Felip E; Hospital Vall d'Hebron, Barcelona, Spain.
  • Carcereny E; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain.
  • García-Campelo R; Complexo Hospitalario Universitario La Coruña, La Coruña, Spain.
  • Viteri S; Instituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain.
  • González-Cao M; Instituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain.
  • Morales-Espinosa D; Instituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain.
  • Verlicchi A; Ospedale Santa Maria delle Croci, Ravenna, Italy.
  • Crisetti E; Department of Medical and Surgical Sciences, Institute of Respiratory Diseases, University of Foggia, Foggia, Italy.
  • Chaib I; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Santarpia M; Human Pathology Department, Medical Oncology Unit, University of Messina, Messina, Italy.
  • Luis Ramírez J; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Bosch-Barrera J; Catalan Institute of Oncology, Hospital Josep Trueta, Girona, Spain.
  • Felipe Cardona A; Clinical and Traslational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia.
  • de Marinis F; Divisione di Oncologica Toracica, Direttore, Istituto Europeo di Oncologia-IEO, Milano, Italy.
  • López-Vivanco G; Chief, Medical Oncology Service, Hospital de Cruces, Barakaldo, Vizcaya, Spain.
  • Miguel Sánchez J; Medical Oncology Service, Hospital de la Princesa, Madrid, Spain.
  • Vergnenegre A; Hôpital du Cluzeau, Limoges, France.
  • Sánchez Hernández JJ; Unidad de Investigación en Salud Pública CIDICS-UANL, Monterrey, Mexico.
  • Sperduti I; Biostatistics, Regina Elena National Cancer Institute, Rome, Italy.
  • Bria E; Department of Medical Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Rosell R; Instituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain. rrosell@iconcologia.net.
Sci Rep ; 13(1): 3620, 2023 Mar 03.
Article em En | MEDLINE | ID: mdl-36869103
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha